Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure

PURPOSE: To assess the prophylactic and treatment activity of reproxalap, a novel reactive aldehyde species inhibitor, in a real-world model of allergen exposure. METHODS: In a randomized, double-masked, vehicle-controlled, crossover Phase 2 trial, 70 adult patients with ≥2 years of moderate to seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, David, Karpecki, Paul, Salapatek, Anne Marie, Sheppard, John D, Brady, Todd C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742616/
https://www.ncbi.nlm.nih.gov/pubmed/35018093
http://dx.doi.org/10.2147/OPTH.S345324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742616/
https://www.ncbi.nlm.nih.gov/pubmed/35018093
http://dx.doi.org/10.2147/OPTH.S345324

Ejemplares similares